MiNK Therapeutics Stock Soars 213.07% on Cancer Treatment Breakthrough
-
最新报道：Mink Therapeutics' stock surged 213.07% following a breakthrough in its cancer treatment research. The biotech firm announced promising results from preclinical trials of its novel therapy targeting aggressive tumors. Company CEO Dr. Sarah Chen stated, "Our innovative approach shows significant tumor reduction with minimal side effects in early testing." Analysts attribute the dramatic share price increase to the potential market disruption of Mink's treatment, which could address unmet needs in oncology. The company plans to begin Phase 1 clinical trials next quarter, pending FDA approval. Investors are closely watching Mink's progress as it could revolutionize cancer care for difficult-to-treat malignancies.
下一篇
XRP News Today: HashJ Launches 2025 Digital Asset Mining White Paper for XRP, DOGE, BTC
- HashJ has released its 2025 Digital Asset Mining White Paper, outlining plans to integrate...
24小时热点
热点专题
418271